Table 1 Characteristics for the whole group, women with 12-month, past and no past depressive or anxiety disorder

Age (yr)

50.0 (33.5-65.0)

47.0 (33.8-59.0)^a

46.5 (29.0-59.8)^a

52.0 (35.0-68.0)

<0.001

44.0 (29.0-56.0)^b

54.0 (32.8-64.8)

51.0 (34.0-67.0)

0.008

Weight (kg)

69.4 (61.4-80.8)

72.9 (63.4-82.5)^a

71.7 (62.8-79.9)

68.3 (60.9-80.3)

0.03

72.0 (63.4-80.5)

68.7 (60.4-80.2)

69.0 (61.2-81.0)

0.40

Smoking (current)

149 (14.0%)

33 (22.6%)^a

22 (14.9%)

94 (12.2%)

0.004

21 (21.2%)

6 (15.0%)

122 (13.2%)

0.09

Systolic BP (mmHg)

125.1 ± 17.5

124.2 ± 17.0

123.5 ± 14.7

125.5 ± 18.0

0.41

122.2 ± 17.8

126.7 ± 16.8

125.0 ± 17.4

0.25

Diastolic BP (mmHg)

75.7 ± 11.0

78.0 ± 10.9^a

74.9 ± 9.9

75.4 ± 11.1

0.03

76.1 ± 11.5

76.8 ± 10.7

75.6 ± 10.9

0.75

Mobility (current)

0.10

0.36

 Active

831 (78.4%)

107 (73.3%)

123 (83.7%)

601 (78.4%)

74 (74.8%)

34 (85.0%)

723 (78.5%)

 Sedentary

174 (16.4%)

32 (21.9%)

21 (14.3%)

121 (15.8%)

21 (21.2%)

3 (7.5%)

150 (16.3%)

 Limited

55 (5.2%)

7 (5.3%)

3 (2.3%)

45 (5.9%)

4 (4.0%)

3 (7.5%)

48 (5.2%)

Walking aid (current)

58 (5.5%)

5 (3.4%)^a

3 (2.0%)^a

50 (6.5%)

0.05

5 (5.1%)

1 (2.5%)

52 (5.7%)

0.68

Health status (current)

<0.001

0.04

 Excellent-Very good

621 (58.6%)

64 (43.8%)^a

83 (56.9%)

474 (61.8%)

48 (48.5%) ^b

20 (50.0%)

553 (60.1%)

 Good

322 (30.4%)

52 (35.6%)

50 (34.3%)

220 (28.7%)

36 (36.4%)^b

18 (45.0%)^b

268 (29.1%)

 Fair-Poor

116 (11.0%)

30 (20.6%)^a

13 (8.9%)

73 (9.5%)

15 (15.2%)

2 (5.0%)^b

99 (10.8%)

Alcohol intake (g/d)

2.9 (0.4-12.1)

3.1 (0.4-14.8)

3.9 (0.5-14.7)

2.6 (0.3-10.6)

0.06

2.5 (0.3-13.5)

4.7 (0.4-12.4)

2.8 (0.4-11.7)

0.99

Calcium intake (mg/d)

836.9(607.6-1070.2)

836.1(556.6-1098.5)

794.2(572.6-1045.3)

840.6(617.6-1072.0)

0.43

787.8(549.2-1099.4)

920.1(676.2-1208.9)

836.3(608.1-1065.2)

0.32

Falls (2 or more)

56 (5.3%)

14 (9.6%)^a

9 (6.1%)

33 (4.3%)

0.03

9 (9.1%)

4 (10.0%)

43 (4.7%)

0.07

Socioeconomic status

0.70

0.89

 Quintile 1 (most disadvantaged)

165 (15.4%)

28 (19.2%)

22 (14.9%)

115 (15.0%)

17 (17.2%)

7 (17.5%)

141 (15.3%)

 Quintile 2

229 (21.6%)

32 (21.9%)

30 (20.3%)

167 (21.7%)

23 (23.2%)

6 (15.0%)

200 (21.7%)

 Quintile 3

242 (22.8%)

32 (21.9%)

34 (23.0%)

176 (22.9%)

19 (19.2%)

11 (27.5%)

212 (23.0%)

 Quintile 4

210 (19.8%)

31 (21.2%)

25 (16.9%)

154 (20.1%)

22 (22.2%)

6 (15.0%)

182 (19.7%)

 Quintile 5

216 (20.3%)

23 (15.8%)

37 (25.0%)

156 (20.3%)

18 (18.2%)

10 (25.0%)

188 (20.4%)

Psychotropic use (current)

159 (15.0%)

59 (40.4%)^a

33 (23.3%)^a

67 (8.7%)

<0.001

29 (29.3%)^b

16 (40.0%)^b

114 (12.4%)

<0.001

 benzodiazepine use

64 (6.0%)

16 (11.0%)^a

9 (6.1%)

39 (5.1%)

0.02

13 (13.1%)^b

5 (12.5%)^b

46 (5.0%)

0.001

 antidepressant use

120 (11.3%)

54 (37.0%)^a

27 (18.2%)^a

39 (5.1%)

<0.001

23 (23.2%)^b

15 (37.5%)^b

82 (8.9%)

<0.001